ARC
ISEE

Absolute Return Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Absolute Return Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,571
Closed -$193K – 1001
2014
Q2 		$193K Sell
4,571
-22,786
-83% -$836K ﹤0.01% 1022
2014
Q1 		$976K Buy
+27,357
New +$923K 0.01% 630

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Absolute Return Capital's ISEE Position: Q3 2014 in Review

Absolute Return Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2014, closing a stake of 4,571 shares — an estimated $193K sold.

Absolute Return Capital first reported a position in ISEE in Q1 2014 and held it in 2 quarters. The position peaked at $976K in Q1 2014. 92 funds tracked by Wall St. Rank hold ISEE as of Q3 2014.

  • Absolute Return Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Absolute Return Capital sold 4,571 IVERIC bio, Inc. Common Stock shares in Q3 2014, an estimated $193K.
  • Absolute Return Capital first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 2 quarters.
  • Absolute Return Capital's IVERIC bio, Inc. Common Stock position peaked at $976K in Q1 2014.
  • 92 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.